Search results
Results from the WOW.Com Content Network
Like hepatic adenomas, they are diagnosed with imaging and biopsies as needed. Treatment of liver cell adenomatosis is difficult due to the multiple, widespread lesions. Liver imaging should be reviewed to see if it is possible to surgically remove the tumors. [7] Liver transplantation is a treatment option for some patients. [7]
The PAIR (puncture-aspiration-injection-reaspiration; sometimes percutaneous aspiration-injection-reaspiration [1]) procedure is a noninvasive treatment option to remove hydatid cysts. [2] PAIR is considered an alternative treatment for cystic echinococcosis ( hydatid disease ) and is often indicated for patients who do not respond to surgery ...
Another primary malignant liver tumor is the cholangiocarcinoma. Hepatectomy may also be the procedure of choice to treat intrahepatic gallstones or parasitic cysts of the liver. [citation needed] Partial hepatectomies are also performed to remove a portion of a liver from a living donor for transplantation. [3]
Polycystic liver disease (PLD) usually describes the presence of multiple cysts scattered throughout normal liver tissue. [1] PLD is commonly seen in association with autosomal-dominant polycystic kidney disease, with a prevalence of 1 in 400 to 1000, and accounts for 8–10% of all cases of end-stage renal disease. [2]
Only 30% of cysts disappear with medical treatment alone. Albendazole is preferred twice a day for 1–5 months. [39] An alternative to albendazole is mebendazole for at least 3 to 6 months. Surgery is indicated for bigger liver cysts (> 10 cm), cysts at risk of rupture and/or complicated cysts.
Choledochal cysts are treated by surgical excision of the cyst with the formation of a roux-en-Y anastomosis hepaticojejunostomy/ choledochojejunostomy to the biliary duct. Future complications include cholangitis and a 2% risk of malignancy, which may develop in any part of the biliary tree. A recent article published in the Journal of Surgery ...
The family of 70-year-old William Bryan claims surgeon Thomas Shaknovsky removed his liver and not his spleen during a procedure he did not survive.
[7] [8] Nevertheless, surgery for resectable metastases has become the standard of care, [9] probably making such a trial infeasible. [2] [7] Previously, liver metastasectomy was limited to patients with less than four sites of metastasis in the liver, with a tumour-free margin of at least 1 centimetre, and no cancer elsewhere.